- Home
- NVVEW vs VCEL Comparison
NVVEW vs VCEL Comparison
Compare NVVEW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVVEW | VCEL |
|---|---|---|
| Founded | N/A | 1989 |
| Country | China | United States |
| Employees | 12 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 2.0B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | NVVEW | VCEL |
|---|---|---|
| Price | $0.01 | $35.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $57.50 |
| AVG Volume (30 Days) | N/A | ★ 417.8K |
| Earning Date | N/A | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 236.54 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $258,716,999.00 |
| Revenue This Year | N/A | $18.02 |
| Revenue Next Year | N/A | $18.52 |
| P/E Ratio | ★ N/A | $145.81 |
| Revenue Growth | N/A | ★ 14.05 |
| 52 Week Low | N/A | $29.24 |
| 52 Week High | N/A | $58.77 |
Technical Indicators
Market Signals| Indicator | NVVEW | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 42.11 |
| Support Level | $0.01 | $33.30 |
| Resistance Level | $0.02 | $36.56 |
| Average True Range (ATR) | 0.00 | 1.56 |
| MACD | -0.00 | -0.27 |
| Stochastic Oscillator | 0.00 | 28.50 |
Price Performance
Historical ComparisonAbout NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.